Tizoxanide as a novel theraputic candidate for osteoarthritis

Area of Science:

• Biomedical Science
• Pharmacology
• Rheumatology

Background:

• Osteoarthritis (OA) is a prevalent degenerative joint disease in the elderly.
• Inflammation and altered autophagy are key factors in OA pathogenesis.
• Tizoxanide (Tiz), an active metabolite of nitazoxanide, possesses known anti-inflammatory properties.

Purpose of the Study:

• To investigate the anti-arthritic effects of Tiz in a rat model of OA.
• To elucidate the underlying molecular mechanisms of Tiz action in OA.
• To evaluate Tiz as a potential therapeutic agent for OA.

Main Methods:

• In vitro studies using rat chondrocytes treated with IL-1β.
• In vivo assessment of Tiz efficacy in a surgically induced rat OA model.
• Analysis of inflammatory markers, cartilage matrix, autophagy, and signaling pathways (PI3K/AKT/mTOR, P38/JNK).

Main Results:

• Tiz attenuated IL-1β-induced inflammation, cartilage damage, and autophagy reduction in chondrocytes.
• The autophagy inhibitor 3-methyladenine (3-MA) reversed the protective effects of Tiz.
• Tiz inhibited IL-1β-induced PI3K/AKT/mTOR and P38/JNK phosphorylation.
• Intra-articular Tiz injection reduced cartilage damage progression in the rat OA model.

Conclusions:

• Tiz demonstrates significant anti-arthritic effects in both in vitro and in vivo OA models.
• Tiz acts, in part, by modulating autophagy and inhibiting key inflammatory signaling pathways.
• Tizoxanide represents a promising therapeutic candidate for osteoarthritis management.